Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cybin

Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education

Psychedelics-focused biotech company Cybin Inc. (NYSE: CYBN) announced that it has formed a partnership with The Chopra Foundation, a not-for-profit founded by alternative medicine and new age author Deepak Chopra.

Benzinga · Feb 16, 2022

Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event

Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psychedelic Spotlight, announced that Psychedelic Spotlight will host its first “CEO Roundtable” on Feb. 15.

Benzinga · Feb 14, 2022

Mind Medicine, Cybin Among Top Psychedelic Movers Of Today

GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI Life SciencesGAINERS:

Benzinga · Feb 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Allied, Cybin Among Top Psychedelic Movers Of Today

GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89

Benzinga · Feb 10, 2022

Cybin Receives U.S. Patent For Its Proprietary DMT Compound To Treat Anxiety Disorders

Psychedelics company Cybin Inc. (NEO: CYBN) (AMEX: CYBN) announced that the U.S. Patent and Trademark Office has granted U.S. patent 11,242,318 to the company’s investigational deuterated dimethyltryptamine (“DMT”) compound CYB004.

Benzinga · Feb 9, 2022

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today

GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62

Benzinga · Feb 8, 2022

Psychedelic Stock Gainers And Losers From January 18, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07

Benzinga · Jan 18, 2022

Read news from The Economist, FT, and more,
with one subscription

1 2

Coverage From

People

Deepak Chopra

44 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Psychedelic Spotlight

Read news from The Economist, FT, and more,
with one subscription

Places

United States

424,530 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.